Benson Hill Biosystems Launches the First Fully Enabling Genome Editing System for Crop Improvement

System Available to Partners to Leverage Natural Plant Genetic Diversity LONDON, Oct. 19, 2017 /PRNewswire/ — Benson Hill Biosystems, an agricultural technology company dedicated to unlocking the natural genetic potential of plants, today announced at the Future Food-Tech Conference the commercial launch of Edit, powered by CropOS™, the first complete genome editing system made accessible to partners for the development of... Read more

Thermo Fisher Scientific and Wellcome Trust Sanger Institute Announce the Axiom Africa Array for Medical and Population Genomics

Thermo Fisher Scientific and Wellcome Trust Sanger Institute Announce the Axiom Africa Array for Medical and Population Genomics SANTA CLARA, Calif., Oct. 19, 2017 /PRNewswire/ — Thermo Fisher Scientific today announced the commercial launch of the Applied Biosystems Axiom Africa Array for medical and population genomics to accelerate and support initiatives in global health and population... Read more

10x Genomics Announces the Addition of Unbiased Gene Expression and B-cell Repertoire to the Chromium™ Single Cell V(D)J Solution

– New products for profiling adaptive immunity will be presented at the 67th Annual Meeting of the American Society of Human Genetics (ASHG) held in Orlando, FL – PLEASANTON, CA.—October 18, 2017— 10x Genomics, a company focused on enabling the mastery of biology by accelerating genomic discovery, this week will launch new products for their... Read more

Fluidigm to Unveil High-Parameter Tissue Imaging System

SOUTH SAN FRANCISCO, Calif., Oct. 18, 2017 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced that it will unveil a commercially available system for high-parameter tissue imaging on Tuesday, October 24, 2017, via a global livestream video. This new imaging system significantly expands the number of protein biomarkers that can be simultaneously detected from tissues and tumors as compared to... Read more

CEM Introduces the Future of Molecular Sample Preparation

MATTHEWS, N.C., Oct. 17, 2017 /PRNewswire/ — CEM Corporation, a leading supplier of sample preparation systems, is pleased to introduce the all new EDGE™ extraction system for rapid sample preparation of GC/LC samples.  Featuring advanced Q-Cup™ Technology, the EDGE™ can prepare samples for molecular analysis in as little as 5 minutes with exceptional recovery and repeatability. “The EDGE™ is a simple solution... Read more

Agilent Expands SureGuide Portfolio with CRISPR-based Products to Accelerate Disease Research

New CRISPR-based Transcriptional Activation and Interference (a/i) Libraries SANTA CLARA, Calif., October 17, 2017 Agilent Technologies Inc. (NYSE: A) today announced the first expansion of the SureGuide pooled CRISPR libraries for functional genomics, offering pooled libraries for CRISPR activation and interference (CRISPR a/i). The announcement was made at the at the American Society for Human... Read more

PerkinElmer Launches chemagic Prime Instrument for Automated Nucleic Acid Isolation and Assay Set-Up

PerkinElmer Launches chemagic™ Prime™ Instrument for Automated Nucleic Acid Isolation and Assay Set-Up Leverages Advanced Magnetic Bead-Based Technology to Support Next Gen Sequencing, Genotyping, PCR and MLPA in Human Samples   WHAT:              PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its chemagic™ Prime™ instrument, a new streamlined,... Read more

Roche to present new OCREVUS (ocrelizumab) efficacy and safety data in relapsing and primary progressive forms of multiple sclerosis at ECTRIMS

Basel, 16 October 2017 Roche to present new OCREVUS (ocrelizumab) efficacy and safety data in relapsing and primary progressive forms of multiple sclerosis at ECTRIMS Largest body of OCREVUS data presented at a congress to date reinforce favourable benefit-risk profile and advance clinical understanding of disease progression Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today... Read more

Roche to present new OCREVUS (ocrelizumab) efficacy and safety data in relapsing and primary progressive forms of multiple sclerosis at ECTRIMS

Basel, 16 October 2017 Roche to present new OCREVUS (ocrelizumab) efficacy and safety data in relapsing and primary progressive forms of multiple sclerosis at ECTRIMS Largest body of OCREVUS data presented at a congress to date reinforce favourable benefit-risk profile and advance clinical understanding of disease progression Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today... Read more